Management Changes

QuadraMed Corporation (NASDAQ: QDHC) today announced the appointment of Michael J. Simpson as the Company's Senior Vice President, Product Strategy and Development.

In this capacity, Mr. Simpson will lead QuadraMed's product strategy, product development, and technology/architecture operations. Mr. Simpson has more than fifteen years of domestic and international management experience across various market segments, including healthcare information technology, telecommunications, media and high tech industries. Mr. Simpson was previously with McKesson Corporation, where he served in multiple executive roles, including Senior Vice-President and Chief Technology Officer, McKesson Provider Technologies, Senior Vice President and Chief Technology Officer for McKesson Technology Solution's International Operations, and Senior Vice-President and General Manager, Horizon Clinicals. Mr. Simpson brings extensive experience to QuadraMed in product life cycle management and technology development and deployment for a comprehensive range of clinical and financial solutions including electronic health records.

In addition to his experience at McKesson, Mr. Simpson held the roles of General Manager and Vice President in telecommunications and media at Unisys Corporation from 2002 to 2004 and Novell Corporation from 1992 to 2002. He began his career as an applications engineer at Signetics Semiconductor Corporation. Mr. Simpson holds a degree in design engineering from Brigham Young University in 1989 and a B.S. in Management from the University of Phoenix in 2009.

Kathryn E. Falberg, the Chief Financial Officer and Chief Operating Officer of ARCA biopharma, Inc. (NASDAQ: ABIO), resigned from her position with the Company, effective immediately, in order to pursue other professional opportunities. The announcement was made on November 30, 2009.

Deere & Company (NYSE: DE) announced today that its Board of Directors has elected Samuel R. Allen as Chairman of the Board, effective at the conclusion of the Feb. 24, 2010 annual meeting of stockholders. Allen will continue as Deere & Company president and chief executive officer.

Allen is a 34-year veteran of Deere with a broad range of leadership experience in many divisions of the company. Allen has served as a senior officer at Deere since 2001, was president of the Worldwide Construction & Forestry Division and also led Deere Power Systems Group, John Deere Credit's global operations, and Deere's global human resources and labor relations.

The action is another step in Deere & Company's systematic process of leadership transition that was announced in June. Allen will become chairman immediately following expiration of Robert W. Lane's current term as chairman and member of the Deere Board of Directors. The Board also voted to reduce the size of the Board to 11 members, effective at the same time as Allen becomes Chairman.

In June, Deere & Company announced that its Board of Directors had elected Allen to become president and chief operating officer, as well as a member of the Board of Directors effective June 1st, and chief executive officer effective August 1st.

Sequenom, Inc. (NASDAQ: SQNM), today announced that Dr. Yves Ville has joined the company's Clinical Advisory Board. Dr. Ville is a prominent obstetrician-gynecologist and currently serves as professor and chairman of the department of obstetrics and fetal medicine at Necker-Enfants-Malades Hospital at the Paris Descartes University.

Dr. Ville received his medical degree from Paris University. He served his internship and Residency in Surgery and in Obstetrics and Gynecology at teaching hospitals located in Paris, and at the Harris Birthright Research Centre, King's College Hospital in London.

Dr. Ville was appointed Consultant and Senior Lecturer in Obstetrics and Gynecology and Director of the Fetal Medicine Unit at St Georges' Hospital and Medical School in London in 1996. In 1998 he was made Full Professor and Chairman of the Department of Obstetrics and Gynecology in Poissy Hospital and Paris-Ouest University. In 2008 he became Chairman of the department of Obstetrics and Fetal Medicine at Necker-Enfants-Malades Hospital, Paris Descartes University.

Newell Rubbermaid (NYSE: NWL) today announced the appointment of Juan R. Figuereo as Executive Vice President and Chief Financial Officer. Figuereo, 54, is a former Wal-Mart and PepsiCo executive with significant experience in global general management, operations, and strategic mergers and acquisitions, in addition to senior financial leadership. He will join Newell Rubbermaid on Dec. 7 and succeeds J. Patrick Robinson, who is taking early retirement as previously announced.

Figuereo began his career at Arthur Andersen & Co. in Miami, specializing in banking, insurance and information systems consulting. A Certified Public Accountant, he received a Bachelor of Business Administration in Public Accounting from Florida International University. Figuereo is a native of the Dominican Republic who is fluent in English, Spanish and Portuguese.